All News
Filter News
Found 809,105 articles
-
FDA Panel Rejects Zogenix, Inc. Painkiller
12/12/2012
-
Insights Into the Genetic Causes of Coronary Artery Disease and Heart Attacks, Wellcome Trust Sanger Institute Study
12/12/2012
-
Eating Too Much? Blame It on Facebook, Not Holiday Treats, Columbia University and University of Pittsburgh Study
12/12/2012
-
Derma Sciences, Inc. Closes $36.4 Million Underwritten Public Offering of Common Stock
12/12/2012
-
Pancreas Size May Help Unlock Cause of Type 1 Diabetes, University of Florida Study
12/12/2012
-
Sucampo Pharmaceuticals, Inc. Gets Nod for Glaucoma Drug From FDA
12/12/2012
-
Pfizer Inc. Rigged Canadian Viagra Patent Filing: Lawsuit
12/12/2012
-
How Our Sense of Touch is a Lot Like the Way We Hear, University of Chicago Study
12/12/2012
-
Pharmacyclics, Inc. Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Hematology (ASH) Annual Meeting
12/12/2012
-
FibroGen, Inc. and Astellas Pharma Inc. Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease
12/12/2012
-
Biogen Idec, Inc. (North Carolina), Eisai Inc. Team Up at Research Triangle Park Facilities
12/12/2012
-
Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
12/12/2012
-
ARCA biopharma Release: Gencaro Cardiovascular Effect on Patients With Atrial Fibrillation Paper Published in European Journal of Heart Failure
12/12/2012
-
Novo Nordisk A/S Bets on Turning Victoza Into Obesity Blockbuster
12/12/2012
-
XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
12/12/2012
-
Celgene International Sárl Release: Data Evaluating Combination Treatments Including REVLIMID® Plus Antibody Therapies in Patients With Various Difficult-to-Treat Forms of Non-Hodgkin Lymphoma Presented at the 54th American Society of Hematology Annual Me
12/12/2012
-
Milo Biotechnology Announces DSG, Inc. Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
12/12/2012
-
Unigene Laboratories, Inc.'s Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
12/12/2012
-
Positive Results Achieved in Vernalis PLC' Receptor Occupancy Study of V8144 for Parkinson's Disease and Other CNS Indications
12/12/2012
-
Theravance, Inc. Announces Initiation of Phase 2b Study With Its LAMA Candidate, TD-4208, for the Treatment of COPD
12/12/2012